focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 440.00
Bid: 430.00
Ask: 450.00
Change: 0.00 (0.00%)
Spread: 20.00 (4.651%)
Open: 440.00
High: 445.00
Low: 440.00
Prev. Close: 440.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re. Tristel Italia srl

6 Feb 2008 13:19

Tristel PLC06 February 2008 TRISTEL plc Establishment of Tristel Italia srl Tristel plc ("Tristel"), the AIM listed provider of infection and contaminationcontrol products, announces that it has taken a 20% interest in Tristel Italiasrl ("TI"), a company incorporated in Italy and established to commercialiseTristel's product portfolio in the country. TI was incorporated on 9 October2007. Prior to Tristel becoming a shareholder TI was wholly-owned by Mr MichaelDonaldson. Mr Donaldson, aged 51, was Country Manager, Italy and Greece, for Fuji HuntPhotographic Chemicals until June 2006. During the past eighteen months MrDonaldson has been assessing the potential of the Italian market for Tristel. Heis resident in Milan. Tristel is providing a loan facility to TI to fund its early stage developmentand has an option to increase its shareholding in TI from 20% to 51%. PaulSwinney, Chief Executive of Tristel, assumes the position of President of TI andMichael Donaldson its Managing Director. Commenting on Tristel's involvement in TI and the Italian market, Paul Swinneyexplains: "The development of our export business is proceeding well. In all the exportmarkets which we are currently penetrating we are working with distributors.Whilst this model is highly effective its limitations can be exposed as theTristel product portfolio continues to expand. We address specific niches withinthe hospital market and it can be difficult to identify a distributor capable ofexploiting them all successfully. "Michael has been known to us for many years and is well qualified to build theTristel business in Italy. The Italian hospital market has many similarities tothe United Kingdom's. We are very encouraged to have already secured TI's firstcustomers in the Ear, Nose and Throat market, an area we dominate in our homemarket. "This investment for international expansion represents a departure from ourpresent export market development model. However, the investment is modest andwe believe that a direct presence in Italy will accelerate significantly ourpenetration of this major European market." Contacts: Tristel plc Paul Swinney, Chief Executive Tel: 01638 721 500 Daniel Stewart & Company PlcOliver Rigby Tel: 020 7776 6550 Parkgreen Communications Ltd Tel: 020 7479 7933Paul McManus Mob: 07980 541 893 paul.mcmanus@parkgreenmedia.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Nov 201811:31 amRNSDirector/PDMR Shareholding
19th Nov 20187:00 amRNSAcquisition & Board Appointment
5th Nov 20188:35 amRNSIssue of Equity
17th Oct 20187:00 amRNSFinal Results
13th Sep 20187:00 amRNSNotice of Results
24th Aug 20187:00 amRNSIssue of Equity
23rd Aug 20187:00 amRNSIssue of Equity
19th Jul 20184:21 pmRNSHolding(s) in Company
19th Jul 20183:55 pmRNSHolding(s) in Company
16th Jul 20185:49 pmRNSResult of secondary placing
16th Jul 20181:53 pmRNSProposed secondary placing of Ordinary Shares
13th Jul 20187:00 amRNSTrading update & Notice of results
12th Jun 20184:39 pmRNSIssue of Equity
11th Jun 20182:37 pmRNSDirector/PDMR Shareholding
8th Jun 20187:00 amRNSShareholder Open Day
7th Jun 20188:15 amRNSIssue of Equity
1st Jun 20183:50 pmRNSDirector/PDMR Shareholdings
15th May 20188:14 amRNSHolding(s) in Company
11th May 20185:45 pmRNSDirector/PDMR Shareholding
10th May 20188:26 amRNSHolding(s) in Company
8th May 20189:51 amRNSIssue of Equity
2nd May 20184:55 pmRNSDirector/PDMR Dealing and Issue of Equity
23rd Apr 20187:00 amRNSEPA approval received
13th Apr 20182:55 pmRNSIssue of Equity
27th Mar 20188:19 amRNSIssue of Equity
26th Mar 20187:00 amRNSCommercial collaboration with Parker Laboratories
8th Mar 201810:58 amRNSIssue of Equity
20th Feb 20187:00 amRNSHalf-year Report
8th Feb 20182:19 pmRNSHolding(s) in Company
26th Jan 20187:00 amRNSIssue of Equity
24th Jan 20187:00 amRNSStudy shows comparable efficacy of Tristel Wipes
17th Jan 20187:00 amRNSInvestor results presentation
12th Dec 20172:57 pmRNSResult of AGM
12th Dec 20177:00 amRNSAGM Statement & notice of results
27th Nov 201710:35 amRNSIssue of Equity
23rd Nov 20173:24 pmRNSClarification of AGM timing
14th Nov 201710:34 amRNSIssue of Equity
2nd Nov 20177:00 amRNSDirectors dealing/grant of options
23rd Oct 20174:41 pmRNSIssue of Equity
19th Oct 20177:01 amRNSDirector Appointment
19th Oct 20177:00 amRNSFinal Results
3rd Oct 20177:00 amRNSTiming of EPA approval
19th Sep 20177:00 amRNSInvestor results presentation
18th Sep 20171:44 pmRNSIssue of Equity
22nd Aug 201712:08 pmRNSIssue of Equity
18th Aug 20171:31 pmRNSDirector/PDMR Dealing - replacement
17th Aug 20177:00 amRNSDirector/PDMR Dealing
7th Aug 20172:29 pmRNSIssue of Equity
24th Jul 20179:46 amRNSIssue of Equity
19th Jul 20177:00 amRNSTrading update & Notice of results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.